Published online Apr 26, 2023. doi: 10.12998/wjcc.v11.i12.2684
Peer-review started: January 6, 2023
First decision: January 30, 2023
Revised: February 20, 2023
Accepted: March 23, 2023
Article in press: March 23, 2023
Published online: April 26, 2023
Processing time: 109 Days and 13.7 Hours
Premature ovarian insufficiency (POI) is characterized by the premature decline of ovarian function, inducing secondary amenorrhea and leading to severe infertility. Excessive production of reactive oxygen species (ROS) induces DNA damage, lipid peroxidation, and protein denaturation, while oxidative stress causes or exacerbates various diseases. The function of mitochondria in the ovaries and the cytotoxicity associated with ROS have been implicated in follicle pool depletion and follicle quality decline. Diacron-reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) can be easily measured, and tests have been developed for the comprehensive evaluation of blood oxidative stress by combining the d-ROMs and BAP tests.
Most cases of POI are idiopathic, and no definitive cause has yet been identified. Investigation of the cause of POI, early diagnosis, and early intervention are warranted.
This study sought to comprehensively assess the oxidative stress status with d-ROMs and BAP tests in POI and to investigate whether these can be biomarkers for POI.
To comprehensively assess oxidative stress status, we measured plasma d-ROM and BAP in POI and control groups.
The d-ROMs level and the oxidase stress index were significantly higher in the POI than in the control group. However, the BAP level did not significantly differ between the two groups.
Oxidative stress (d-ROMs, OSI) in the POI group was significantly higher than in the control group, suggesting that the oxidative stress state may be a factor in POI and a potential biomarker. Therefore, it may be useful for early intervention for treatment, including infertility treatment.
Oxidative stress was significantly higher in patients with POI than in healthy controls, suggesting the use of this measurement as a biomarker of POI. In the future, we plan to investigate whether these markers are useful for the early diagnosis of POI and how the state of oxidative stress affects the pathology of POI.